Gene-Edited Therapy Access Fund
A social investment fund that utilizes pooled resources and risk mitigation strategies (like diversified treatment portfolios) to make responsive implant therapies accessible to underserved populations struggling with chronic diseases exacerbated by existing health inequities. Prioritizes preventative care to reduce the need for more extensive, expensive interventions later.